Dr. Amir Hussein Faraji, MD, PhD

Dr. Faraji practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Faraji's NPI, 1457610776, was assigned on May 7, 2012. Dr. Faraji graduated from University of Pittsburgh School of Medicine in 2013. Dr. Faraji holds Texas license S6611.

Dr. Faraji's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Faraji's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Faraji is also affiliated with Houston Methodist West Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Faraji to 2 more hospitals, 5 home health agencies, 2 group practices and clinics, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faraji practices, 12 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Faraji's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Faraji is board certified in board certified by the American Board of Neurological Surgery. Dmand AI has Dr. Faraji's licenses on file in 3 states: Texas, Missouri and Pennsylvania.

Dmand AI lists craniotomy, lower back pain and spinal fusion among the conditions Dr. Faraji treats.

CMS data shows 537 Medicare services from Dr. Faraji across 14 procedure codes in 2024, for 245 Medicare patients. Medicare paid $219,425 for them.

CMS counts 245 Medicare patients who saw Dr. Faraji in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Faraji's median patient age at 71, with 49% women.

In 2024, Dr. Faraji wrote 504 Medicare Part D claims for 220 patients. 100% of them were for generic drugs. CMS names the drug for 454 of them, across 4 drugs with 11 or more claims each, at $3,173 in total drug cost. In 2023, CMS named 445 claims across 6 drugs.

Dr. Faraji accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Faraji as offering telehealth.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 88 papers to Dr. Faraji, published from 2011 to 2025. 2024 was the busiest year, with 14. The most frequent topics are Radiosurgery, Spinal Cord Injuries and Lumbar Vertebrae. Dr. Faraji has published most often in World Neurosurg. Dr. Faraji's most frequent co-authors are Jaime Raul Guerrero, MD, Paul Gardner and Ezequiel Dario Goldschmidt, MD, PhD.

Dmand AI links Dr. Faraji to 4 clinical trials. 4 are still active or recruiting. Conditions studied include Quadriplegia, Spinal Cord Injuries and Paralysis. The Methodist Hospital Research Institute sponsors the most, 2.

CMS Open Payments shows 348 general payments to Dr. Faraji from 21 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 41% of the total. Abbott Laboratories paid the most, $26,932.

Dmand AI lists 14 awards for Dr. Faraji, most recently Fellow (FACS), American College of Surgeons in 2024.

Dr. Faraji graduated from University of Pittsburgh School of Medicine in 2013. Dr. Faraji is a member of AANS, ACS, AMA, ASSFN and CNS.

Dr. Faraji is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.